Yellow Fever vaccine is one of the most efficacious human vaccines ever made. The vaccine (YF 17D) virus induces polyvalent immune responses, with a mixed TH1/TH2 CD4+ cell profile, which results in robust T CD8+ responses and high titers of neutralizing antibody. In recent years, it has been suggested that early events after yellow fever vaccination are crucial to the development of adequate acquired immunity. We have previously shown that primary immunization of humans and monkeys with YF 17D virus vaccine resulted in the early synthesis of IFN-γ. Herein we have demonstrated, for the first time that early IFN-γ production after yellow fever vaccination is a feature also of murine infection and is much more pronounced in the C57BL/6 strain compared to the BALB/c strain. Likewise, in C57BL/6 strain, we have observed the highest CD8+ T cells responses as well as higher titers of neutralizing antibodies and total anti-YF IgG. Regardless of this intense IFN-γ response in mice, it was not possible to see higher titers of IgG2a in relation to IgG1 in both mice lineages. However, IgG2a titers were positively correlated to neutralizing antibodies levels, pointing to an important role of IFN-γ in eliciting high quality responses against YF 17D, therefore influencing the immunogenicity of this vaccine.
We have previously designed a method to construct viable recombinant Yellow Fever (YF) 17D viruses expressing heterologous polypeptides including part of the Simian Immunodeficiency Virus (SIV) Gag protein. However, the expressed region, encompassing amino acid residues from 45 to 269, was genetically unstable. In this study, we improved the genetic stability of this recombinant YF 17D virus by introducing mutations in the IRES element localized at the 5′ end of the SIV gag gene. The new stable recombinant virus elicited adaptive immune responses similar to those induced by the original recombinant virus. It is, therefore, possible to increase recombinant stability by removing functional motifs from the insert that may have deleterious effects on recombinant YF viral fitness.
The flaviviral envelope proteins, E protein and precursor membrane protein, are mainly associated with the endoplasmic reticulum (ER) through two transmembrane (TM) Key words: recombinant yellow fever 17D virus -GFP expression -ER retention -deletion and insertion mutants Yellow fever (YF) virus is the prototype member of the genus Flavivirus of the Flaviviridae family. The YF genome consists of a 10,832-nucleotide (nt) positive, single-stranded RNA and contains a single open reading frame that is translated into a 3410-amino acid polyprotein precursor. The specific proteolytic cleavage of this precursor by cellular proteases and the viral NS2B/NS3 proteolytic complex leads to the generation of structural proteins [the C, precursor membrane (PrM), M and E constituents of the viral particle] and the nonstructural proteins (the NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5 components of the viral replicative complex). During flavivirus cell propagation, there is an extensive rearrangement of endoplasmic reticulum (ER)-derived membranes that raises specialised and distinct sites of viral replication and assembly (Mackenzie 2005, Welsch et al. 2009, Gillespie et al. 2010. The E and prM proteins, which are the envelope proteins, are translocated to the ER and exposed to the luminal face of this compartment. Both proteins remain associated with the ER membrane through their carboxy-terminal regions, which consist of a pair of antiparallel helices traversing the membrane (Zhang et al. 2003). The E protein is the major constituent of the flaviviral envelope. In the infectious viral particle, E protein exists as a slightly bent, elongated head-to-tail dimer that is orientated parallel to the viral membrane. The E monomer has three domains in its ectodomain portion: the structurally central, N-terminal domain I, followed by the dimerisation domain II, and the carboxy-terminal, Ig-like domain III. The carboxy terminus of approximately 100 amino acid residues is denominated of stem-anchor (SA) region. The stem is composed of two α-helixes buried in the outer leaflet of the viral membrane and the anchor is composed of two antiparallel, coiled-coil transmembrane (TM) domains. Similarly, alpha-helix near the N terminus of prM/M is partially submerged in the outer lipid bilayer and the carboxy-terminal region of M consists of a pair of antiparallel helices traversing the membrane (Zhang et al. 2003).Previous studies have shown that the majority of intracellular prM and E is localised to the ER as stable heterodimers; indeed, heterodimer formation between prM and E starts shortly after synthesis (Lorenz et al. 2002). The viral particles are formed by the budding of the nucleocapsid into the lumen of the ER, which is subsequently covered by the envelope lipid membrane with a network of anchored E and prM proteins. The prM/E association appears essential for preventing protein E from suffering low-pH rearrangements during transport through the acidic compartments of the trans-Golgi network. In this compartment, shortly before the vir...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.